Andrea Cox, MD, PhD Professor of Medicine and Oncology, Director, Medical Scientist Training Program
Andrea Cox is a Professor of Medicine and Oncology. She earned her Ph.D. studying T cell immunology at The University of Virginia. She subsequently completed an M.D. and then Internal Medicine and Infectious Disease training at Johns Hopkins. She investigates human immune responses to hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, dengue virus, and HIV, including mechanisms through which these viral infections stimulate and evade immune responses. She focuses on immune responses to vaccines against viral pathogens, including in immunocompromised populations, and in HCV vaccine development. She is the PI of a U19 investigating mechanisms of spontaneous HCV control to direct rational development of an effective HCV vaccine and is the co-director of the Johns Hopkins SARS-CoV-2 Pathogenesis and Immunity Center. She was the principal investigator on the first prophylactic HCV vaccine trial implemented in an at-risk population and is the lead immunologist on an ACTG trial of HBV vaccines in people living with HIV.
